Skip to main navigation Skip to search Skip to main content

Inhibition of breast cancer resistance protein at the murine blood-brain barrier by Ko143 studied with [11C]tariquidar and PET

  • T. Wanek (Speaker)
  • , Claudia Kuntner
  • , Jp Bankstahl
  • , M Bankstahl
  • , J Stanek
  • , Michael Sauberer
  • , M Müller
  • , W Löscher
  • , Oliver Langer

    Research output: Chapter in Book or Conference ProceedingsConference Proceedings with Oral Presentation

    Original languageEnglish
    Title of host publicationSupplement to BMC Pharmacology
    Pages48
    Number of pages1
    Publication statusPublished - 2011
    Event17th Scientific Symposium of the Austrian Pharmacological Society - APHAR 2011 -
    Duration: 29 Sept 201130 Sept 2011

    Conference

    Conference17th Scientific Symposium of the Austrian Pharmacological Society - APHAR 2011
    Period29/09/1130/09/11

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Research Field

    • Former Research Field - Health and Bioresources

    Cite this